NAD+ Biology and Its Decline With Age

What NAD+ is

NAD+ (nicotinamide adenine dinucleotide) is found in all living cells. It is a coenzyme, meaning a helper molecule that enzymes need to do their work. It takes part in energy metabolism and also feeds enzymes that act as sensors and repair helpers, including sirtuins, PARP-1 and CD38. [1] Cells also make NADH, the other form of the same molecule, and the balance between the two is called the redox state. [2]

Cells keep NAD+ topped up mostly through a recycling route (the "salvage pathway") run by an enzyme called NAMPT. [1] NMN and nicotinamide riboside are called NAD+ precursors because the body can use them to make NAD+. [3] Their human trial results are on separate pages: NMN and nicotinamide riboside.

This page is education only. It does not advise using any product.

Does NAD+ fall with age?

The answer depends on what was measured and where.

• Human brain, imaging study. Researchers developed a non-invasive magnetic resonance method to measure NAD in the living human brain. In healthy volunteers they reported age-dependent reductions in NAD+, in total NAD and in the NAD+/NADH balance, and an increase in NADH. The authors read this as a sign of declining mitochondrial function with normal aging. [2] This is a cross-sectional comparison of different people at different ages, not a follow-up of the same people over time.
• Muscle. A 2022 review explains that aging and muscle contraction both increase NAD+ use, while replenishment can be limited by the supply of precursors and by enzyme levels. [1] That describes a mechanism; it is not a measurement in a particular person.
• Blood. A 2026 review of intravenous NAD+ states that recent large-scale human data indicate whole-blood NAD+ concentrations do not decline with healthy aging per se. [4] The review does not name the individual studies in its abstract, so treat this as one expert summary.
• Overview. A 2026 Annual Review of Nutrition article says diminished NAD+ has been linked to several hallmarks of aging, but that it remains unclear whether aging drives metabolic decline, whether metabolic problems speed aging, or both. [5]

Put together, "NAD+ declines with age" is a reasonable summary for some tissues and studies, but it is not a settled, body-wide fact, and a blood test is not a reliable stand-in for what is happening in the brain or muscle.

Why animal results do not settle it

Reviews of rodent studies commonly report that raising NAD+ was linked to better metabolic, mitochondrial and inflammatory results, although effects varied across models and measures. [3] Label: preclinical (cells or animals only). In people, the same review found that oral NR and NMN reliably raised NAD-related markers but that effects on functional and metabolic outcomes were heterogeneous and often null. [3]

Raising a blood marker is not the same as better health

Two examples show why. In a 14-day trial of 65 healthy adults, NR and NMN raised circulating NAD+ in a similar way, and laboratory work suggested gut bacteria may convert them to nicotinic acid along the way. The study was run by employees of a food company and looked at levels, not health outcomes. [6] In a 12-week pilot in people with mild cognitive impairment, blood NAD+ doubled with NR, yet the main cognition measure did not improve. [7] Biomarker change is not a clinical outcome.

What is still unknown

• Whether low NAD+ in a given tissue causes age-related problems or follows from them. [5]
• Whether raising NAD+ in blood changes NAD+ inside the tissues that matter.
• Whether any NAD+ strategy changes how long or how well people live. The 2026 systematic review called clinical effectiveness for anti-aging or wellness inconclusive. [3]

Evidence label for "NAD+ boosting slows human aging": insufficient evidence. Claims on product pages that go further are marketing claims; see NAD, NMN and longevity claims and Claim Check: NAD+ boosters restore youthful energy.